Caption Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-175,000
Closed -$17.9M 1718
2025
Q4
$17.9M Sell
175,000
-82,500
-32% -$7.38M 0.12% 199
2025
Q3
$16.1M Buy
257,500
+117,500
+84% +$6.39M 0.13% 177
2025
Q2
$7.29M Buy
140,000
+80,000
+133% +$3.57M 0.08% 295
2025
Q1
$2.56M Buy
+60,000
New +$2.59M 0.02% 607
2024
Q2
Sell
-16,600
Closed -$342K 1290
2024
Q1
$342K Buy
+16,600
New +$356K 0.01% 936
2023
Q2
Sell
-40,000
Closed -$938K 1217
2023
Q1
$938K Hold
40,000
0.02% 653
2022
Q4
$1.09M Sell
40,000
-129,700
-76% -$5.93M 0.02% 722
2022
Q3
$9.13M Sell
169,700
-39,000
-19% -$2M 0.13% 191
2022
Q2
$8.42M Buy
208,700
+73,200
+54% +$3.63M 0.12% 225
2022
Q1
$8.97M Buy
+135,500
New +$9.27M 0.11% 252
2020
Q1
Sell
-19,300
Closed -$1.51M 931
2019
Q4
$1.51M Buy
+19,300
New +$1.39M 0.05% 414

Other funds holding GH

Caption Management's GH Position: Q1 2026 in Review

Caption Management opened a new position in Guardant Health (GH) in Q1 2026: 115,183 shares worth $10.6M. The stake represents 0.06% of the portfolio and ranks #311 among its holdings. This is a return to the name: Caption Management previously reported a position in GH as recently as Q1 2025.

Caption Management first reported a position in GH in Q4 2019 and has held it in 12 quarters since. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Caption Management held 115,183 shares of Guardant Health worth $10.6M as of Q1 2026.
  • Guardant Health was a new Caption Management position in Q1 2026.
  • Guardant Health made up 0.06% of Caption Management's portfolio in Q1 2026, its #311 holding.
  • Caption Management first reported a position in Guardant Health in Q4 2019 and has held it in 12 quarters since.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.